Tau prions from Alzheimer’s disease and chronic traumatic encephalopathy patients propagate in cultured cells
Tau prions are thought to aggregate in the central nervous system, resulting in neurodegeneration. Among the tauopathies, Alzheimer’s disease (AD) is the most common, whereas argyrophilic grain disease (AGD), corticobasal degeneration (CBD), chronic traumatic encephalopathy (CTE), Pick’s disease (Pi...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS Vol. 113; no. 50; pp. E8187 - E8196 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
National Academy of Sciences
13-12-2016
|
Series: | PNAS Plus |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Tau prions are thought to aggregate in the central nervous system, resulting in neurodegeneration. Among the tauopathies, Alzheimer’s disease (AD) is the most common, whereas argyrophilic grain disease (AGD), corticobasal degeneration (CBD), chronic traumatic encephalopathy (CTE), Pick’s disease (PiD), and progressive supranuclear palsy (PSP) are less prevalent. Brain extracts from deceased individuals with PiD, a neurodegenerative disorder characterized by three-repeat (3R) tau prions, were used to infect HEK293T cells expressing 3R tau fused to yellow fluorescent protein (YFP). Extracts from AGD, CBD, and PSP patient samples, which contain four-repeat (4R) tau prions, were transmitted to HEK293 cells expressing 4R tau fused to YFP. These studies demonstrated that prion propagation in HEK cells requires isoform pairing between the infecting prion and the recipient substrate. Interestingly, tau aggregates in AD and CTE, containing both 3R and 4R isoforms, were unable to robustly infect either 3R- or 4R-expressing cells. However, AD and CTE prions were able to replicate in HEK293T cells expressing both 3R and 4R tau. Unexpectedly, increasing the level of 4R isoform expression alone supported the propagation of both AD and CTE prions. These results allowed us to determine the levels of tau prions in AD and CTE brain extracts. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Author contributions: A.L.W., A.A., S.H.O., and S.B.P. designed research; A.L.W., A.A., S.P., S.A.K., and L.T.G. performed research; I.L., L.T.G., A.C.M., and W.W.S. contributed new reagents/analytic tools; A.L.W., A.A., S.P., I.L., S.H.O., and S.B.P. analyzed data; and A.L.W., A.A., S.H.O., and S.B.P. wrote the paper. 1A.L.W. and A.A. contributed equally to this work. Reviewers: R.H.B., University of Massachusetts Medical School; and D.W., University of Alberta. Contributed by Stanley B. Prusiner, October 6, 2016 (sent for review August 5, 2016; reviewed by Robert H. Brown Jr. and David Westaway) |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.1616344113 |